glp-1 parkinson's disease lancet receptor agonists and next-generation incretin-based medications: metabolic, cardiovascular, and renal benefits Why Did a GLP-1 Receptor
Description
A study involving 20 patients demonstrated a beneficial effect of GLP-1 RAs on the severity of psoriasis in obese patients [77]
STAT3 is widely expressed in the CNS
It follows that the use of incretinomimetics activating the GLP-1R pathway may be an interesting lead for treating OA
Rojas M, Chavez-Castillo M, Bautista J, Ortega A, Nava M, Salazar J, et al
Schweizer A, Dejager S, Foley JE et al
